- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05614635
Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression
Prospective, Multicenter, Observational cLinical triAl Measuring Safety and Technical Performance of plAstalgin and Plastalgin Fast in Patients Requiring a Dental Impression
The aim of this study is to gather clinical data related to the use of Plastalgin and Plastalgin Fast, in order to comply with the new medical device regulation. The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults.
Collection, recording, and reporting of data will be accurate and will ensure the privacy, health, and welfare of participating patients during and after the study
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montigny-le-Bretonneux, France, 78180
- Cabinet dentaire
-
Paris, France, 75011
- Cabinet dentaire
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults.
Minors are eligible to participate in the study. Other vulnerable patients can be included in the study as there is no additional risk for this population.
Description
Inclusion Criteria:
- Patient fulfilling all the following criteria is eligible for the clinical investigation:
- Male or female patient ≥ 5 years of age.
- Indication of dental impressions for the fabrication of prosthesis such as mouth guards and trays, total or partial dentures, and fixed prosthesis (crowns, bridges, dental veneers).
- Total or partially edentulous patient or patient with disocclusion or patient with misalignment.
- Patient affiliated or beneficiary of a social security system.
- Written informed consent must be obtained before any study-related assessment is performed.
Exclusion Criteria:
- The presence of any of the following exclusion criteria will lead to the exclusion of the patient:
- Inability to comply with study procedures.
- Patient opposing the processing of their data.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anatomical reproductibility of the dental impression with Plastalgin and Plastalgin Fast.
Time Frame: Immediately after the procedure.
|
Dentist's opinion through a questionnaire completed by the dentist
|
Immediately after the procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of impressions needed per patient
Time Frame: Immediately after the procedure.
|
Number of impressions needed per patient to make a quality impression.
|
Immediately after the procedure.
|
|
Setting time of Plastalgin and Plastalgin Fast
Time Frame: During the procedure.
|
Measure of the setting time by the dentist at each use of Plastalgin and Plastalgin Fast
|
During the procedure.
|
|
Rate of adverse events
Time Frame: During and immediately after the procedure.
|
Cumulative number of adverse events and serious adverse events
|
During and immediately after the procedure.
|
|
Rate of device-related adverse event
Time Frame: During and immediately after the procedure.
|
Cumulative number of adverse events and serious adverse events related to Plastalgin or Plastalgin Fast
|
During and immediately after the procedure.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Stephanie INDUNI, MD, Cabinet dentaire
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PLAS 2022-02
- 2022-A00882-41 (Other Identifier: BRC Identification number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Malocclusion
-
Ahmed Talaat Hussein AliCompletedDental Malocclusion | Dental CrowdingEgypt
-
University of PaviaCompleted
-
LightForce OrthodonticsCompletedDental MalocclusionCanada
-
Region Örebro CountyRecruitingStability | Dental MalocclusionSpain, Sweden
-
Al-Azhar UniversityActive, not recruiting
-
University of SalamancaCompletedDental MalocclusionSpain
-
Cairo UniversityUnknownDental MalocclusionEgypt
-
Al-Azhar UniversityCompletedDental Malocclusion
-
Tharwat osman Mohi Eldeen ElshehawyCompleted
-
Al-Azhar UniversityRecruiting
Clinical Trials on Plastalgin and Plastalgin Fast
-
Ottawa Hospital Research InstituteCompleted
-
The Netherlands Cancer InstituteCompleted
-
University of NottinghamCompletedTime Restricted FeedingUnited Kingdom
-
University of AarhusUnknown
-
West Park Healthcare CentreCompletedChronic Obstructive Pulmonary DiseaseCanada
-
University Health Network, TorontoCompleted
-
Haitian Group for the Study of Kaposi's Sarcoma...Brigham and Women's Hospital; Weill Medical College of Cornell University; Florida...Unknown
-
Centre Hospitalier St AnneCompleted
-
Emory UniversityUnited States Department of DefenseCompletedAbdominal TraumaUnited States
-
Maisonneuve-Rosemont HospitalActive, not recruiting